Synapse - Works

Results (4808)

Elevated hemoglobin concentration and risk of acute myocardial infarction and venous thromboembolism

Meeting Abstract

Hultcrantz, M.; Modlitba, A.; Vasan, S. K.; Sjolander, A.; Rostgaard, K.; Landgren, O.; Hjalgrim, H.; Kristinsson, S. Y.; Edgren, G.
Haematologica (2015)

Fulltext@MSK | Save

Parental longevity and survival in patients with multiple myeloma and MGUS

Meeting Abstract

Sverrisdottir, I. S.; Lund, S. H.; Turesson, I.; Bojrkholm, M.; Goldin, L. R.; Landgren, O.; Kristinsson, S. Y.
Haematologica (2015)

Fulltext@MSK | Save

Family history of lymphoproliferative disease associated with a superior survival in multiple myeloma: A population-based study

Meeting Abstract

Aradttir, K.; Lund, S. H.; Bjorkholm, M.; Goldin, L. R.; Turesson, I.; Landgren, O.; Kristinsson, S. Y.
Haematologica (2015)

Fulltext@MSK | Save

Obesity and risk of monoclonal gammopathy of undetermined significance: A population-based study

Meeting Abstract

Thordardottir, M.; Lindqvist, E.; Lund, S. H.; Costello, R.; Burton, D.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; Launer, L. J.; Gudnason, V.; more...
Haematologica (2015)

Fulltext@MSK | Save

Minimum follow-up of 4 years for ongoing patients with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib

Meeting Abstract

Talpaz, M.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D. L.; Flinn, I. W.; O'Hare, T. J.; Hu, S.; Rivera, V. M.; Clackson, T.; more...
Haematologica (2015)

Fulltext@MSK | Save

Long-term follow-up of ponatinib efficacy and safety in patients (PTS) with the T315I mutation in the phase 1 and phase 2 (PACE) trials

Meeting Abstract

Baccarani, M.; Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Kantarjian, H. M.; Shah, N. P.; Bixby, D.; more...
Haematologica (2015)

Fulltext@MSK | Save

Clinical assessment of chronic lymphocytic leukemia samples for somatic hypermutation status by next-generation sequencing and Sanger sequencing

Meeting Abstract

Arcila, M.; Huang, Y.; Hutt, K.; Panganiban, J.; Baldi, T.; Nafa, K.; Thornes, J.; Miller, J. E.; Klass, M.
Haematologica (2015)

Fulltext@MSK | Save

Improved survival in patients ≥60 with first relapsed/refractory acute myeloid leukemia treated with vosaroxin plus cytarabine vs placebo plus cytarabine: Results from the phase 3 valor study

Meeting Abstract

Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Erba, H. P.; more...
Haematologica (2015)

Fulltext@MSK | Save

Allogeneic transplant in patients ≥60 years of age with first relapsed or refractory acute myeloid leukemia after treatment with vosaroxin or placebo plus cytarabine: Results from VALOR

Meeting Abstract

Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Erba, H. P.; Pigneux, A.; Horst, H. A.; more...
Haematologica (2015)

Fulltext@MSK | Save

Retreatment with blinatumomab after CD19-positive relapse: Experience from 3 trials in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R ALL)

Meeting Abstract

Topp, M. S.; Stelljes, M.; Zugmaier, G.; Barnette, P.; Heffner, L. T.; Trippett, T.; Bargou, R.; Jia, C.; Benjamin, J.; Litzow, M. R.
Haematologica (2015)

Fulltext@MSK | Save